Testing is our standard
Testing is a fundamental part of our quality standards. We believe that every product must meet strict purity and identity criteria before reaching our customers.
Skip to product information
Reta
€39,99
Reta is an investigational synthetic peptide–based drug candidate developed to target metabolic disorders, especially obesity and type 2 diabetes. It belongs to a newer class of so-called triple-agonists, meaning it activates three types of receptors involved in metabolic regulation. Specifically, retatrutide is designed to act on GLP-1, GIP, and glucagon receptors, mimicking hormones known as incretins that help regulate appetite, glucose metabolism, and energy expenditure.
Retatrutide has been shown in clinical studies to significantly reduce body weight and improve glucose control, largely by decreasing appetite, slowing gastric emptying, improving insulin sensitivity, and increasing energy expenditure. In addition to weight loss and glycemic control, researchers are investigating its effects on blood lipids, liver fat content, and markers related to cardiometabolic health.
This peptide comes in the form of lyophylized powder.